Boardroom Alpha
Meeting calendar
UHT · Annual meeting · Wednesday, June 10, 2026

Universal Health Realty Income Trust

7 nominees · 4 ballot items.

Shareholders will vote to elect two Class I Trustees, cast an advisory (nonbinding) vote to approve named executive officer compensation (“say-on-pay”), ratify KPMG LLP as the Trust’s independent registered public accounting firm for the fiscal year ending December 31, 2026, and transact any other business properly brought before the meeting.

Market cap
$608M
1Y TSR
+11.9%
Board grade
C-
Record date
Apr 13, 2026
Filing
DEF 14A
Meeting concluded · Jun 10, 2026

Follow how the vote landed and what changed on Universal Health Realty Income Trust’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot4

  1. 1

    Election of Two Class I Trustees

    ManagementBoard: FOR

    Election of two Class I Trustees (Alan B. Miller and Robert F. McCadden) to serve three-year terms expiring in 2029.

  2. 2

    Advisory Vote on Named Executive Officer Compensation

    ManagementBoard: FOR

    Nonbinding advisory ("say-on-pay") vote to approve the compensation paid to the Trust’s named executive officers as disclosed in the proxy statement.

    More detail

    This management proposal requests a non-binding, advisory approval of the Trust’s named executive officer (NEO) compensation as disclosed in the proxy materials, effectively asking shareholders to endorse the overall compensation philosophy and disclosed pay outcomes rather than any single element of pay. Management is seeking approval to demonstrate shareholder support for its compensation practices, which rely heavily on stock-based long-term incentives and an advisory arrangement with UHS that provides executive personnel and services; the proxy highlights enhanced disclosures about the Advisor fee, allocation of Advisor-paid compensation, and UHT stock awards to improve transparency. The Trust frames this vote as an annual opportunity for shareholders to express their views and notes that the Compensation Committee will consider the voting outcome when setting future compensation, though the vote remains non-binding. Contextually, the Trust has historically structured executive pay largely through restricted stock awards and an advisory fee to UHS; the proxy discloses how advisory fees and equity awards compare to peer groups and provides a pay-versus-performance analysis. Management emphasizes that enhanced disclosures have correlated with strong historical shareholder support (95% in 2024, 94% in 2023, and 93% in 2022) to justify continued reliance on the current program. The board’s recommendation to vote FOR is grounded in its view that the compensation program aligns executives’ interests with long-term shareholder value, that advisory and equity arrangements are reasonable versus peers, and that recent grant practices (fixed-dollar equity awards tied to peer benchmarking and TSR-based performance metrics) provide appropriate incentives. The proposal is procedurally an ordinary majority vote and is informational to investors and governance stakeholders; because it is advisory, a negative result would not automatically change pay but would prompt the Compensation Committee to reassess policies and disclosures. Analysts should weigh the Trust’s dependence on an external advisor, the concentration of revenue with UHS-related tenants, and the relatively simple compensation structure when evaluating whether a ‘‘FOR’’ recommendation signals substantive alignment or primarily reflects customary practice at advisor-managed REITs.

  3. 3

    Ratification of the Selection of Independent Registered Public Accountants

    ManagementBoard: FOR

    Ratify the Audit Committee’s selection of KPMG LLP as the Trust’s independent registered public accounting firm for the fiscal year ending December 31, 2026.

  4. 4

    Transaction of Other Business

    Management

    Transact such other business as may properly come before the meeting or any adjournment thereof (discretionary matters), with proxies granted discretionary authority to vote on such matters.

Director elections

Nominees on the ballot7

Not independent
Tenure on this board
40.5 yrs
Also a director at
Universal Health Services Inc (UHS)
Not independent
Tenure on this board
17.6 yrs
Also a director at
Universal Health Services Inc (UHS)
Ownership

Top institutional holders10

Latest 13F quarter
1BlackRock, Inc.10.4%1,444,825$58M
2VANGUARD PORTFOLIO MANAGEMENT LLC6.9%957,786$39M
3VANGUARD CAPITAL MANAGEMENT LLC4.3%595,253$24M
4STATE STREET CORP4.0%559,260$23M
5BlackRock, Inc.3.3%451,970$18M
6MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.2.5%340,130$14M
7GEODE CAPITAL MANAGEMENT, LLC2.2%307,014$12M
8RENAISSANCE TECHNOLOGIES LLC1.6%220,110$9M
9BlackRock, Inc.1.5%211,465$9M
10DIMENSIONAL FUND ADVISORS LP1.3%177,493$7M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Universal Health Realty Income Trust 2026 annual meeting?
Universal Health Realty Income Trust (UHT) holds its 2026 annual shareholder meeting on Wednesday, June 10, 2026.
What is the record date for the Universal Health Realty Income Trust 2026 meeting?
The record date for the Universal Health Realty Income Trust 2026 meeting is Monday, April 13, 2026. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Universal Health Realty Income Trust's 2026 meeting?
The board is presenting 7 director nominees at the Universal Health Realty Income Trust 2026 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Universal Health Realty Income Trust 2026 meeting?
Shareholders will vote on 4 proposals at the Universal Health Realty Income Trust 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer